The recent newly listed Beijing Stock Exchange (BSE) IPOs are truly undervalued.

Recently, four newly listed stocks on the Beijing Stock Exchange have had modest opening-day gains. After listing, they all saw sharp declines. After falling for several days, the valuations are really low.

Longyuan Shares has a P/E ratio of 16; its current price is 33.67 yuan, up 36% from its issue price.
Puang Medical has a P/E ratio of 21; its current price is 36 yuan, up 96% from its issue price.
Yuelong Technology has a P/E ratio of 22; its current price is 24.28 yuan, up 72% from its issue price.
Xin Hengtai has a P/E ratio of 23; its current price is 15.9 yuan, up 69% from its issue price.

The P/E ratio of the BZSE 50 is 51. The valuations of these new stocks are all less than half of the BZSE 50. Because new listings on the Beijing Stock Exchange are issued at P/E ratios below 15, I thought that even if the BZSE 50 fell to 600 points, the new stocks wouldn’t go below the issue price. But now it looks like once it drops below 1000 points, they will go below the issue price.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin